The down-regulation of transcriptional co-activators CREBBP (or CBP), and SMAD5, with NF-α1/CPE transfection in hippocampal cells is interesting and suggest that they may participate in preventing NF-α1/CPE mediated AD pathology. The gene discussed is SMAD5; the disease is Alzheimer disease.